ABOUT THIS EVENT
Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, visited the Nasdaq Entrepreneurial Center in San Francisco.
In honor of the occasion, George Scangos, CEO, rang the Opening Bell.